Screening for latent tuberculosis before tumour necrosis factor antagonist therapy

European Respiratory Journal

Volumn 45, Issue 5, 2015, Pages 1510-1512

  Hewitt, Richard J ^a   Singanayagam, Aran ^a   Sridhar, Saranya ^b   Wickremasinghe, Melissa ^a,b   Kon, Onn Min ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CORTICOSTEROID; ETANERCEPT; ISONIAZID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

FALSE POSITIVE RESULT; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LETTER; LIVER TOXICITY; MASS SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; TUBERCULIN TEST;

EID: 84929000719     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00194314     Document Type: Letter

References (15)

1. Woodfield G, Passey-Heaton B, Chakrabarti A, et al. An evaluation of the use of a negative interferon-γ release assay for tuberculosis screening before TNF antagonist therapy. Eur Respir J 2014; 44: 1369-1372.
2. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment. Thorax 2005; 60: 800-805.
3. Singanayagam A, Manalan K, Sridhar S, et al. Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy. Thorax 2013; 68: 955-961.
4. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: A systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011; 56: 230-238.
5. Chen DY, Shen GH, Chen YM, et al. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: The utility of IFNγ assay. Ann Rheum Dis 2012; 71: 231-237.
6. Mariette X, Baron G, Tubach F, et al. influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis 2012; 71: 1783-1790.
7. Kleinert S, Tony H, Krueger K, et al. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions. Ann Rheum Dis 2012; 71: 1791-1795.
8. Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005; 52: 1766-1772.
9. The ongoing problem of tuberculosis in the UK. Lancet 2013; 381: 1431.
10. Dixon WG, Hyrich KL, Watson KD, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 2010; 69: 522-528.
11. Abreu C, Magro F, Santos-Antunes J, et al. Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population. J Crohns Colitis 2013; 7: e486-e492.
12. Diel R, Loddenkemper R, Zellweger JP, et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 2013; 42: 785-801.
13. World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva, World Health Organization, 2015. Available from: www.who.int/tb/publications/ltbi-document-page/en/.
14. D'Ambrosio L, Dara M, Tadolini M, et al. Tuberculosis elimination: Theory and practice in Europe. Eur Respir J 2014; 43: 1410-1420.
15. Ruan Q, Zhang S, Ai J, et al. Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: A systemic review and meta-analysis. Clin Rheumatol 2014 [In pressDOI:10.1007/s10067-014-2817-6].